You just read:

Pradaxa® (dabigatran etexilate mesylate) Capsules Gains Preferred Formulary Status with AARP®, Nation's Largest Provider of Medicare Part D Coverage

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

May 19, 2011, 08:00 ET